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The incidence of Sexually Transmitted 
Diseases in Prospective Semen Donors 
where investigated using Standard 
Laboratory Procedures. 30 Prospective 
Semen Donors were screened for 
common STDs/STI at the Human 
Reproductive Research Programme 
/Invitro Fertilization Centre of the 
University of Benin Teaching Hospital. 
The incidence rates are Staphylococcus 
aureus (20%), followed by Chlamydia 
trachomatis (6.7%) while Klebsiellia spp, 
Treponema pallidum, Human 
Immunodeficiency Virus (HIV), 
Escherichia coli and Hepatitis B Virus 
were detected with incidence rate of 
3.3% each respectively. Ten percent 
(10%) of the prospective semen donors 
had evidence of polymicrobial infection 
excluding HIV. The risk of sexually 
transmitted diseases or infection should 
be of great concern to couples 
undergoing therapeutic artificial donor 
insemination. 
Keywords: STDs/STI, Artificial 
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INTRODUCTION 
 Therapeutic donor insemination 
has become well-established option in 
the treatment of un-correctable male-
factor infertility. The use of donor semen 
has increased dramatically in recent 
years and thousands of infants are 
conceived worldwide by artificial 
insemination with the use of donor 
semen. Despite its wide acceptance 
among physicians and infertile couples, 
recent reports of contaminated semen 
continue to cause considerable 
concern2,3. Many individuals presenting 
as potential semen donors, who are 
infected with several pathogens may 
lack symptoms and signs of infection, or 
may not have clinically detectable 
evidence of infection, thereby placing 
the recipient at significant risk. Efforts to 
reduce the risk of transmitting infection 
during artificial insemination with donor 
semen include adoption of the 
guidelines recommended by the 
American Fertility Society. These 
guidelines recommend rigorous 
 
 
screening of Potential semen donors for 
sexually transmitted disease (STDs) and 
that the sperm be frozen and 
quarantined for a period of six to twelve 
months while the donor undergoes 
repeated testing for development of 
antibodies to the human 
immunodeficiency virus (HIV)4.  
    Despite the comprehensive 
guidelines of several professional and 
governmental agencies screening 
therapeutic insemination donors for 
sexually transmitted disease, available 
data suggest that the standard of 
practice is highly variable7. Several 
programmes appear to take inadequate 
measures to prevent STD transmission 
by limiting screening to entry only 
without frequent retesting, while some 
continue to use fresh sperm and content 
that the recommended screening 
procedures are cumbersome and 
expensive. The long-term sequela of 
infecting a healthy semen recipient with 
STDs clearly justifies rigorous 
screening, although this practice may 
reduce the pool of suitable donors. 
These guidelines are not being 
universally applied. Not only do some 
donor insemination programmes 
especially in developing countries, 
continue to use fresh semen5,6. Others 
use semen cultures as an alternative to 
urethral cultures inspite of the paucity of 
data on the reliability of semen cultures 
as a screening too7. 
Previous studies have reported 
the Incidence of Sexually Transmitted 
Diseases among Potential Semen 
Donors. From June 1986 through 
August 1987 in Houston Texas, for 48 
healthy male volunteers presented as 
potential semen donors. 10% of the 
donor had evidence of sexually 
transmitted disease1,3,9.  
 The main focus of this study, and 
focus is to ascertain the incidence of 
Common Sexually Transmitted 
Pathogens in male subjects Presenting 
to our Clinic as Prospective Semen 
Donors using current screening 
guidelines. 
 
MATERIALS AND METHODS 
 32 prospective semen donors, 
ranging in age from 30 to 40years were 
recruited of the Human Reproduction 
Research Programme/Invitro 
Fertilization Centre of the Hospital from 
January 2007 to August 2008. Semen, 
urine, Urethral discharge and blood 
were collected from each of the donor.  
 All of the samples were rapidly 
transferred to Microbiology Lab of the 
Hospital and Standard Microbiology 
Techniques was performed to detect the 
microbial agents (on Blood agar, 
MacConkey and Chocolate agar for 
Bacteriogical culture incubated at 
370Celcius for 24-48hours. After 
Incubation Period, Specific diagnostic 
tests according to microbiology 
references were performed to 
reorganize the known colonies8,10. In 
addition, Standard Serological Methods 
were applied for the detection of 
Treponema palladum, Chlamydia 
trachomatis and Human 
Immunodeficiency Virus in blood 
samples. Semen parameter was 




Demographic characteristic of the 
Prospective Semen Donors, showed a 
predominantly single male in 
heterosexual relationship and 30% gave 
a history of at least one previous 
episode of Sexually Transmitted 
Diseases (STDs). A total of 15(50%) 
 
 
microbial agents were isolated from the 
30 Prospective Donors screened within 
the period under study. Staphylococcus 
aureus had 6(20%) followed by 
Chlamydia trachomatis 2(6.%), while 
Klebsielia spp, Treponema pallidum 
Human Immunodeficiency Virus, 
Esacherichia coli and Hepalitis B Virus 
had 3.3% incidence rate. 3(10%) had 
evidence of Polymicrobial Infection 
excluding Human Immunodeficiency 
Virus. Positive findings in this study 
were predicted by history of more than 
one partner.   
TABLE I: AGE CLASSIFICATION OF SEMEN DONORS WITH SEXUALLY  
    TRANSMITTED DISEASES 
 
Age (Yrs) Numb. Exam. Numb. Positive % Positive  
20 - 24  10 4 40 
25 – 29 14 10 71 
30 – 34 3 1 33 
35 – 39 2 0 0 
> 40 1 0 0 
Total  30 15 50 
 
TABLE II: NUMBER OF MICROBIAL PATHOGEN PER SPECIMEN FROM  
       PROSPECTIVE SEMEN DONORS IN UBTH  
 
Microbial pathogen  Processed specimen                  
 Urethral discharge  Urine Semen  Blood      Total 
Staphylococcus aureus  5(16%)  (0%) 3(10%)     -           6(20%) 
Klebsiellia Spp. 0(0%) (0%)) 1(3.3%     -          1(3.3%) 
Escherichia coli 0(0%) 1(3.3%) 0(0%)                  1(3.3%) 
Chlamydia trachomatis  - - -   2(6.7%)    2(6.7%) 
Treponema pallidum  - - -   1(3.3%)    1(3.3%) 
Human Immunodeficiency Virus  - - -   1(3.3%)    1(3.3%) 
Hepatitis B Virus - - -   1(3.3%)    1(3.3%) 




 Artificial insemination with donor 
semen has become a well established 
alternative for couples with untreatable 
male factor infertility. Because of the 
widespread use of donor insemination, 
and the increasing awareness and 
prevalence of sexually transmitted 
diseases, It has become imperative to 
subject prospective semen donors for 
sexually transmitted screening. 
 The incidence rate of sexually 
transmitted disease from this study was 
50% which underscore the concern 
often expressed by women undergoing 
artificial inseminations with donor sperm 
regarding the risk of being infected with 
sexually transmitted pathogen. 
 Chlamydia trachomatis ranked 
second in the incidence of STDs in this 
study. Its manifestations are well 
acknowledged in women whom it is 
responsible for majority of cases of 
salpingitis7. Prospective semen donors 
with seroevidence of HIV were rejected. 
In one of the study carried out by Mark 
et al12, the infection rate in 44 enlisted 
semen donors in some fertility centres in 
Canada is 13.6% as against 50% from 
the 30 Semen Donors enlisted in this 
study. It should be noted that 3(10%) 
out of the total number enlisted in this 
study had positive evidence of 
Polymicrobial infections particularly from 
Urethral and Semen Samples from this 
individuals. It was also observed that 
prospective donors in the age group of 
25-29 had the highest incidence of STD 
of 10 (71%), which also underscore the 
need to educate and enlighten our 
youths on the danger of acquiring these 
pathogen. 
Consistent with previous studies 
this finding strengthens the fact that 
Prospective Semen Donors, most of 
whom are young, single, and are not 
always in monogamous relationships, 
represent a high-risk population for STD 
transmission. This predominantly-
student population requires rigorous 
screening and frequent retesting for the 
acquisition of new pathogens. 
Establishing a rapport and good 
communication with this group of highly 
fertile donors, with emphasis on the 
importance of responsible, safe sexually 
behaviours is suggested. The incidence 
of Sexually Transmissible Infections in 
Prospective Semen Donors has been 
reported in some centres controversy 
remains concerning the extent of 
screening that is appropriate for semen 
donors. The major question is whether 
or not the benefit of reducing the risk of 
transmitting STDs compensates for the 
cost of vigorous screening. As screening 
methods continue to improve, and more 
data accumulate on the outcome of 
frequent testing, it appears that such a 
meticulous approach to screening is 
appropriate. With such close 
surveillance and management, the 
transmission of pathogens to semen 
recipients may hopefully be reduced to 
the minimum.  
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